Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
covid
covid-19
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
#683130
Record
· ID 394613
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.